Mgo One Seven LLC Neurocrine Biosciences Inc Transaction History

Mgo One Seven LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$94.11 - $123.02 $51,101 - $66,799	-543 Reduced 10.63%	4,567 $462,000
Q4 2022 Jan 25, 2023	SELL	$106.72 - $127.06 $242,254 - $288,426	-2,270 Reduced 30.76%	5,110 $0
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $26,228 - $30,725	-285 Reduced 3.72%	7,380 $783,000
Q2 2022 Aug 10, 2022	SELL	$75.79 - $100.07 $13,414 - $17,712	-177 Reduced 2.26%	7,665 $747,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $314,360 - $411,380	4,339 Added 123.87%	7,842 $735,000
Q4 2021 Feb 09, 2022	SELL	$79.65 - $106.22 $39,267 - $52,366	-493 Reduced 12.34%	3,503 $298,000
Q3 2021 Nov 09, 2021	SELL	$86.18 - $99.03 $10,083 - $11,586	-117 Reduced 2.84%	3,996 $421,000
Q2 2021 Jul 29, 2021	BUY	$89.43 - $102.27 $178 - $204	2 Added 0.05%	4,113 $400,000
Q1 2021 Apr 29, 2021	BUY	$87.57 - $119.4 $26,708 - $36,417	305 Added 8.01%	4,111 $399,000
Q4 2020 Jan 22, 2021	SELL	$86.91 - $108.33 $30,244 - $37,698	-348 Reduced 8.38%	3,806 $365,000
Q3 2020 Oct 30, 2020	BUY	$96.16 - $135.15 $399,448 - $561,413	4,154 New	4,154 $399,000
Q1 2019 Apr 09, 2019	SELL	$69.31 - $91.53 $14,555 - $19,221	-210 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$68.32 - $124.36 $14,347 - $26,115	210 New	210 $14,000
Q3 2018 Oct 09, 2018	SELL	$98.88 - $125.85 $6,427 - $8,180	-65 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $227 - $277	3 Added 4.84%	65 $5,000
Q4 2017 Feb 16, 2018	BUY	$58.53 - $77.59 $3,628 - $4,810	62	62 $5,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.